Biotechnology at Elizabethtown College

Similar biotechnology bachelor's programs across the nation typically produce starting salaries around $47,000, which aligns with what Elizabethtown's graduates might expect—but that figure comes with an estimated debt load of $24,125. A debt-to-earnings ratio of 0.51 suggests manageable repayment: graduates would owe roughly half their first-year salary, translating to monthly payments around $275 on a standard ten-year plan. That's workable on a biotech salary, though it will take a meaningful bite out of early-career budgets.

The challenge is that we're working entirely with estimates here—both the earnings and debt figures are derived from peer programs nationally, not from tracking Elizabethtown's actual biotechnology graduates. The school's broader profile (77% admission rate, average SAT of 1190, relatively low Pell enrollment at 19%) suggests a solid liberal arts institution, but without program-specific outcomes data, you're essentially betting that Elizabethtown's experience will mirror the national median. That's not unreasonable for a mainstream program at an established college, but it's still a bet.

For families considering this investment, the estimated numbers suggest reasonable financial viability if your student lands squarely in the middle of the pack. But recognize you're making this decision without knowing whether Elizabethtown's specific curriculum, lab facilities, and industry connections produce better or worse outcomes than the typical biotechnology program. If other schools you're considering have actual reported data, that transparency alone might be worth weighing heavily.